Dow Gain Hits Triple Digits; Is Pfizer's Tax Boon a New Trend?

The Dow Jones Industrials moved into further record territory, but can tax-motivated deals like Pfizer's drive the market still higher?

May 12, 2014 at 12:30PM

The Dow Jones Industrials (DJINDICES:^DJI) today built on their record close last Friday, gaining 103 points as of 12:30 p.m. EDT. As the first-quarter earnings season draws to a close, investors appear to have returned their focus to macroeconomic issues that point toward an expanding economy. Yet the number of mergers and acquisitions has been on the rise as well, and controversy about pharma giant Pfizer's (NYSE:PFE) attempt to buy out British drugmaker AstraZeneca has raised speculation about whether tax-motivated mergers could eventually get stomped out by tax-law changes. Still, with Wells Fargo (NYSE:WFC) and countless other companies having benefited from the tax advantages of mergers in the past, it seems shortsighted to single out Pfizer among a long line of actions from thousands of corporate taxpayers designed to reduce taxes.

The pros and cons of tax inversions
Pfizer's buyout offer has attracted so much attention for several reasons. Although many companies have taken steps to move their headquarters outside the U.S. for tax reasons, Pfizer's status as a member of the Dow Jones Industrials and as the largest pharmaceutical-focused company in the nation makes it an extraordinary case.


Source: Phillip Ingham, Flickr.

Moreover, Pfizer has made no attempt to hide the huge potential benefits from having an international tax home. The 35% corporate tax rate in the U.S. is far higher than the 21% rate that applies in the U.K. On top of the business advantages of incorporating complementary drug pipelines and enjoying cost synergies from economies of scale, saving on taxes is a key driver of earnings gains for Pfizer if it can get the merger approved.

The fact that even high-profile companies in the Dow Jones Industrials are looking at the tax-inversion framework makes it even more critical for lawmakers to consider the corporate tax code as a vehicle for enhancing competitiveness and drawing new businesses to the U.S. rather than driving them away. Between the availability of the tax-inversion strategy and the fact that corporations are keeping trillions of dollars locked abroad rather than paying taxes to repatriate their assets, the U.S. Treasury isn't benefiting from high tax rates. Therefore, even though lower tax rates would intuitively reduce tax revenue, the net impact might not be as bad as it looks at first glance.


Perhaps more important, no matter how simple or complex the tax laws get, companies will work to take advantage of opportunities to reap tax benefits. In 2008, for instance, Wells Fargo took advantage of a change in tax law that allowed it to claim loan losses from failing acquisition Wachovia against its own net income. As those losses became available, Wells Fargo was able to use them against its own recovering bottom line, producing far less tax liability than it would have owed without the deal. Many at the time argued that the deal would cost the U.S. government more than a rival proposal that would have involved the FDIC stepping in to handle the bad loans, but in the end, the deal went through and Wells Fargo reaped the rewards.

Taxes are a key part of corporate profitability, and smart companies do whatever they can to reduce their tax bills. Regardless of whether Pfizer is successful in its merger pursuits, you can expect plenty of other companies -- including those in the Dow Jones Industrials -- to follow similar strategies in the future.

Take advantage of this little-known tax "loophole"
Recent tax increases have affected nearly every American taxpayer. But with the right planning, you can take steps to take control of your taxes and potentially even lower your tax bill. In our brand-new special report "The IRS Is Daring You to Make This Investment Now!," you'll learn about the simple strategy to take advantage of a little-known IRS rule. Don't miss out on advice that could help you cut taxes for decades to come. Click here to learn more.

Dan Caplinger owns warrants on Wells Fargo. The Motley Fool recommends Wells Fargo. The Motley Fool owns shares of Wells Fargo and has the following options: short June 2014 $50 calls on Wells Fargo and short June 2014 $48 puts on Wells Fargo. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.


Compare Brokers